retatrutide clinical trials weight loss Effects of once-weekly subcutaneous on and metabolic markers: A systematic review and meta-analysis of randomized controlled Retatrutide Contraindications: Risks and Considerations

In short, no it does not

For additional perspective, heres a list of more studies that show the same: A potential link between liraglutide and thyroid cancer (along with pancreatic and gallbladder problems as well) (3) Study highlighting that liraglutide should not be used in people with a family history of medullary thyroid cancer (4) A study showing there is no increase in the risk of thyroid cancer (for additional perspective) (5) A meta-analysis showing that there is not enough evidence to suggest there is a link between thyroid cancer and GLP-1 agonists (6) Its worth pointing out that while there is still debate on this topic, the larger and bigger studies on this issue seem to support a connection between the two

Dietary considerations are paramount

In contrast, this diet typically lacks essential nutrients such as fibre, vitamins, minerals, and antioxidants found in fresh fruits and vegetables, whole grains, and legumes [104]

In early trials, average weight loss reached 25% by week 4 and up to 24.2% by 48 weeks (12mg dose)